GSK Plc (GSK)
50.25
-0.57
(-1.12%)
USD |
NYSE |
Aug 31, 16:00
50.25
0.00 (0.00%)
After-Hours: 19:22
GSK Total Long Term Debt (Quarterly) : 18.51B for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 18.51B |
| March 31, 2026 | 18.48B |
| December 31, 2025 | 21.96B |
| September 30, 2025 | 20.05B |
| June 30, 2025 | 20.97B |
| March 31, 2025 | 21.26B |
| December 31, 2024 | 20.32B |
| September 30, 2024 | 17.76B |
| June 30, 2024 | 17.16B |
| March 31, 2024 | 19.15B |
| December 31, 2023 | 21.69B |
| September 30, 2023 | 19.52B |
| June 30, 2023 | 19.77B |
| March 31, 2023 | 20.58B |
| December 31, 2022 | 23.27B |
| September 30, 2022 | 21.57B |
| June 30, 2022 | 22.81B |
| March 31, 2022 | 22.43B |
| December 31, 2021 | 31.65B |
| September 30, 2021 | 27.96B |
| June 30, 2021 | 28.24B |
| March 31, 2021 | 31.80B |
| December 31, 2020 | 35.55B |
| September 30, 2020 | 30.17B |
| June 30, 2020 | 31.79B |
| Date | Value |
|---|---|
| March 31, 2020 | 30.68B |
| December 31, 2019 | 33.77B |
| September 30, 2019 | 30.60B |
| June 30, 2019 | 29.67B |
| March 31, 2019 | 30.42B |
| December 31, 2018 | 27.57B |
| September 30, 2018 | 32.35B |
| June 30, 2018 | 32.47B |
| March 31, 2018 | 19.66B |
| December 31, 2017 | 22.08B |
| September 30, 2017 | 19.18B |
| June 30, 2017 | 15.92B |
| March 31, 2017 | 18.26B |
| December 31, 2016 | 21.46B |
| September 30, 2016 | 20.01B |
| June 30, 2016 | 20.18B |
| March 31, 2016 | 22.64B |
| December 31, 2015 | 23.87B |
| September 30, 2015 | 22.88B |
| June 30, 2015 | 23.11B |
| March 31, 2015 | 22.60B |
| December 31, 2014 | 29.29B |
| September 30, 2014 | 30.74B |
| June 30, 2014 | 30.18B |
| March 31, 2014 | 28.74B |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| AstraZeneca PLC | 30.91B |
| Eli Lilly & Co. | 49.62B |
| Merck & Co., Inc. | 51.08B |
| Pfizer Inc. | 63.10B |
| Sanofi | 0.00 |